Humanoid Global Holdings (RBOHF) fair value: what the stock is really worth
As of Oct 30, 2026: fair value (intrinsic value) of Humanoid Global Holdings stock $0.03, price $0.10, upside -72.1%, quality 31 out of 100. Rating: strongly overvalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with oneYes, for free
Humanoid Global Holdings Corp. invests in e-sport, Web 3, and artificial intelligence sectors Canada and the United States. It also invests in NFT, psychedelics, metaverse, and blockchain sectors. The company is headquartered in Vancouver, Canada.
Stock analysis
Humanoid Global Holdings (RBOHF) currently trades at $0.1023, while our model-based Fair Value estimate is $0.0285, 72.1% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 2 models at a data quality of 96/100, which puts the data coverage at low.
Scenario range: $0.0205 (bear) to $0.0365 (bull), the price of $0.1023 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 31/100 (below-average quality), in the Financial Services sector.
Weak Growth: Revenue growth is weak, negative or inconsistent.
Humanoid Global Holdings reported revenue of C$10.5K in FY2026 versus C$6.9K in FY2022, a compound +11.2%/yr. Reported net income was −C$6.0M in FY2026.
Our AI-assisted moat analysis scores the competitive advantage at 5 out of 100 (medium confidence).
What moves the price
The share trades about 94% below its 52-week high and 8% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at −19% fair-value upside, at −72%, RBOHF screens richer than that median.
Fair Value models
Bear$0.0205Fair Value $0.0285Bull$0.0365
Price $0.1023 · Upside -72.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
P/B Multiple$0.0200$0.0300$0.040054
NCAV (Graham)$0.0200$0.0400$0.050051
All 2 models by family
Multiples
P/B Multiple$0.0200$0.0300$0.040054
Asset-Based
NCAV (Graham)$0.0200$0.0400$0.050051
The fair value above starts from this blend and is adjusted for dilution from new shares.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue growth is weak, negative or inconsistent.
Revenue growth 1 year
−5.4%
Revenue growth 8 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.5%
’18
’19
’22
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−15,787.2% (2022) → −57,469.0% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Compare Humanoid Global Holdings with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Asset Management · 653 stocks
Beats the industry median on 1/5 measures
Overall it trails its industry peers.
Valuation
Quality Score31 · Bottom 25%
Fair Value upside−72.1% · Bottom 25%
Profitability
Return on assets−193.6% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY)181.8% · Top 25%
Valuation Multiplesvs Asset Management median · lower = cheaper
P/B1.94× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 60
FUTURE (revenue growth)100· sector 38
PAST (return on equity)0· sector 25
HEALTH (low debt)0· sector 95
DIVIDEND (yield)0· sector 80
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Humanoid Global Holdings Fair Value". https://www.fairvalue-calculator.com/stock/RBOHF
Frequently asked questions
Is Humanoid Global Holdings (RBOHF) overvalued or undervalued?
As of Oct 31, 2026, our model estimates a fair value of $0.0285 versus a price of $0.1023, about −72% upside (overvalued).
What is the fair value of RBOHF?
Our model-based fair value for Humanoid Global Holdings is $0.0285 (as of Oct 31, 2026), built from audited fundamentals. The current price: $0.1023.
What is the quality score of RBOHF?
Humanoid Global Holdings has a Quality Score of 31/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Humanoid Global Holdings (RBOHF)?
Our model-based price target is the fair value of $0.0285 (as of Oct 31, 2026) from 2 valuation models. Cautious scenario $0.0205, optimistic scenario $0.0365. It is a calculation from audited fundamentals, not an analyst target.
What is the Humanoid Global Holdings stock forecast for 2026?
Our models put fair value at $0.0285, about −72% upside versus a price of $0.1023 (overvalued). Cautious scenario $0.0205, optimistic scenario $0.0365. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Humanoid Global Holdings (RBOHF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Humanoid Global Holdings it is $0.0285 per share (as of Oct 31, 2026), against a price of $0.1023. It is the blended result of 2 valuation models (cash flow, earnings, asset, dividend).
Is Humanoid Global Holdings stock overvalued or undervalued in 2026?
As of Oct 31, 2026, RBOHF trades above its calculated fair value: price $0.1023, fair value $0.0285, a gap of about −72% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of RBOHF?
No. The price is what the market pays today ($0.1023); the fair value is what the company's own numbers justify ($0.0285). For Humanoid Global Holdings the two are $0.0738 per share apart. That gap is exactly why we show both numbers side by side.
How much is Humanoid Global Holdings worth?
The market values Humanoid Global Holdings at about $4.6M (market capitalisation, as of Oct 31, 2026). Per share that is $0.1023; our models calculate a fair value of $0.0285 per share.
What do the bullish and bearish scenarios say about RBOHF?
Our models span a range for Humanoid Global Holdings: cautious scenario $0.0205, base $0.0285, optimistic $0.0365 per share (as of Oct 31, 2026, price $0.1023). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Humanoid Global Holdings (RBOHF)?
Balance-sheet figures for Humanoid Global Holdings (as of Oct 31, 2026): return on equity −487.4%. They feed the Quality Score of 31/100, which measures business quality independently of the share price.
How far is RBOHF from its 52-week high?
Humanoid Global Holdings trades at $0.1023, about 94% below its 52-week high of $1.61 and 8% above the low of $0.0945 (as of Oct 30, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0285 is for.
Which stocks are comparable to Humanoid Global Holdings?
From the same area (Financial Services) we also value Blackstone Inc, Brookfield Corporation, KKR & Co, Apollo Global Management, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Humanoid Global Holdings stock attractive at the current price?
The data as of Oct 31, 2026: price $0.1023, calculated fair value $0.0285 (−72%), Quality Score 31/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of RBOHF calculated?
We run Humanoid Global Holdings through 2 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0285, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.5 % above its aggregate fair value. Humanoid Global Holdings itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Humanoid Global Holdings (RBOHF)?
The closing price on Oct 30, 2026 was $0.1023. Our model-based fair value is $0.0285, about −72% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Humanoid Global Holdings right now?
The price sits above even our optimistic bull case ($0.0365). The favourable scenario is already priced in. Weak quality (31/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of Humanoid Global Holdings
How large is the market capitalisation of Humanoid Global Holdings (RBOHF)?
The market capitalisation of Humanoid Global Holdings is $4.6M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Humanoid Global Holdings (RBOHF)?
Earnings per share at Humanoid Global Holdings are $−0.1400. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Humanoid Global Holdings (RBOHF)?
The return on equity (ROE) of Humanoid Global Holdings is −487% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Humanoid Global Holdings (RBOHF)?
On an EBIT basis the return on assets of Humanoid Global Holdings is −131% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Humanoid Global Holdings (RBOHF)?
The operating margin of Humanoid Global Holdings is 1,014% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much revenue does Humanoid Global Holdings (RBOHF) generate?
Humanoid Global Holdings generates revenue of −$1.8M (last twelve months). Revenue of the last twelve months (TTM), the most recent full year, not the calendar year.
How fast is revenue growing at Humanoid Global Holdings (RBOHF)?
Revenue at Humanoid Global Holdings is growing +182% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Humanoid Global Holdings (RBOHF) generate?
The free cash flow of Humanoid Global Holdings is −C$3.1M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Humanoid Global Holdings (RBOHF) hold?
Humanoid Global Holdings holds more cash than debt, C$2.8M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Humanoid Global Holdings in the live analysis
One click puts Humanoid Global Holdings on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 28,000+ stock screener.
Thin data
Oct 31, 2026